Making the Case for Talking to Patients about the Costs of End-of-Life Care

Rileyand G. F. Lubitz J. D. , “Long Term Trends in Medicare Payments in the Last Year of Llife,” Health Services Research 45, no. 2 (2010): 565–576.

Meyerson N. , “The Long-Term Outlook for Health Care Spending,” Office C. B. , Editor, 2007.

See Riley , supra note 1; Hogan C. , “Medicare Beneficiaries' Costs of Care in the Last Year of Life,” Health Affairs 20, no. 4 (2001): 188–195.

Norredam M. , “Financial Status, Employment, and Insurance among Older Cancer Survivors,” Journal of General Internal Medicine 24, no. 2 (2009): 438–435; Weaver K. E. , “Forgoing Medical Care Because of Cost,” Cancer 116, no. 14 (2010): 3493–3504; Langa K. M. , “Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer,” Value in Health 7, no. 2 (2004): 186–194; Blendon R. J. , “Americans' Views of Health Care Costs, Access, and Quality,” Milbank Quarterly 84, no. 4 (2006): 623–657; Szabo L. Appleby J. , “21% of Americans Scramble to Pay Medical, Drug Bills,” USA Today, March 3, 2009; Hanratty B. , “Financial Stress and Strain Associated with Terminal Cancer-a Review of the Evidence,” Palliative Medicine 21, no. 7 (2007): 595–607.

Id. ( Blendon ).

See Weaver , supra note 4.

Emanuel E. J. , “Understanding Economic and Other Burdens of Terminal Illness: The Experience of Patients and Their Caregivers,” Annals of Internal Medicine 132, no. 6 (2000): 451–459.

Id.; McCarthy E. P. , “Dying with Cancer: Patients' Function, Symptoms, and Care Preferences as Death Approaches,” Journal of American Geriatric Society 48, no. 5 (2000): S110-S121; Covinsky K. , “The Impact of Serious Illness on Patients' Families. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment,” JAMA 272, no. 23 (1994): 1839–1844.

See Emanuel , supra note 7.

See Covinsky , supra note 8.

Grunfeld E. , “Family Caregiver Burden: Results of a Longitudinal Study of Breast Cancer Patients and Their Principal Caregivers,” Canadian Medical Association Journal 170, no. 12 (2004): 1795–1801.

Szabo L. , “Cancer Care Can Sap a Lifetime of Savings,” USA Today, July 25, 2008.

Truog R. D. , “Rationing in the Intensive Care Unit,” Critical Care Medicine 34, no. 4 (2006): 958–963; Hurst S. A. Danis M. , “A Framework for Rationing by Clinical Judgment,” Kennedy Institute of Ethics Journal 17, no. 3 (2007): 247–266; Pearson S. D. , “Caring and Cost: The Challenge for Physician Advocacy,” Annals of Internal Medicine 133, no. 2 (2000): 148–153.

Schroeder S. A. Sandy L. G. , “Specialty Distribution of U.S. Physicians – The Invisible Driver of Health Care Costs,” New England Journal of Medicine 328, no. 13 (1993): 961–963.

See Hurst , supra note 13.

Orszag P. R. Emanuel E. J. , “Health Care Reform and Cost Control,” New England Journal of Medicine 363, no. 7 (2010): 601–603.

Daniels N. , Just Health Care (Cambridge: Cambridge University Press, 1985); Daniels N. Sabin J. E. , Setting Limits Fairly, 2nd ed. (New York: Oxford University Press, 2008).

Alexander G. C. Casalino L. P. Meltzer D. O. , “Patient-Physician Communication about Out-of-Pocket Costs,” JAMA 290, no. 7 (2003): 953–958; Piette J. D. Heisler M. Wagner T. H. , “Cost-Related Medication Underuse: Do Patients with Chronic Illnesses Tell Their Doctors?” Archives of Internal Medicine 164, no. 16 (2004): 1749–1755.

See id. ( Alexander )

Singer P. A. Lowy F. H. , “Rationing, Patient Preferences, and Cost of Care at the End of Life,” Archives of Internal Medicine 152, no. 3 (1992): 478–480; Tseng C.-W. , “Patients' Willingness to Discuss Trade-offs to Lower Their Out-of-Pocket Drug Costs,” Archives of Internal Medicine 170, no. 16 (2010): 1502–1504.

Nicholas J. , “ASCO Rx for High Drug Costs: Doctors and Patients Need to Talk,” Journal of the National Cancer Institute 101, no. 21 (2009): 1441–1444; Federman A. D. , “Don't Ask, Don't Tell: The Status of Doctor-Patient Communication about Health Care Costs,” Archives of Internal Medicine 164, no. 16 (2004): 1723–1724.

See Piette , supra note 18; Tseng , supra note 20.

Zuckerman D. M. Kasl S. V. Ostfeld A. M. , “Psychosocial Predictors of Mortality among the Elderly Poor,” American Journal of Epidemiology 119, no. 3 (1984): 410–423; Lantz P. M. , “Socioeconomic Factors, Health Behaviors, and Mortality: Results from a Nationally Representative Prospective Study of US Adults,” JAMA 279, no. 21 (1998): 1703–1708; Berkman L. F. Kawachi I. , Social Epidemiology (New York: Oxford University Press, 2000).

Preamble to the Constitution of the World Health Organization in the International Health Conference, New York, 1946.

Lee T. H. Emanuel E. J. , “Tier 4 Drugs and the Fraying of the Social Compact,” New England Journal of Medicine 359, no. 4 (2008): 333–335; Meropol N. J. , “American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care,” Journal of Clinical Oncology 27, no. 23 (2009): 3868–3874.

See Alexander , supra note 18; Ginsburg M. , Cost-Effectiveness as a Criterion for Medical and Coverage Decisions: Understanding and Responding to Community Perspectives, Sacramento, 2001.

Id. (Ginsburg).

See Piette , supra note 18; Hardee J. T. Platt F. W. Kasper I. K. , “Discussing Health Care Costs with Patients: An Opportunity for Empathic Communication,” Journal of General Internal Medicine 20, no. 7 (2005): 666–669.

See Ginsburg , supra note 26.

See Piette , supra note 18.

See Tseng , supra note 20.

Knaus W. A. Wagner D. P. Lynn J. , “Short-Term Mortality Predictions for Critically Ill Hospitalized Adults: Science and Ethics,” Science 254, no. 5030 (1991): 389–394; Knaus W. A. , “The SUPPORT Prognostic Model: Objective Estimates of Survival for Seriously Ill Hospitalized Adults,” Annals of Internal Medicine 122, no. 3 (1995): 191–203.

See Alexander , supra note 18; Piette , supra note 18; Nelson A. , “Much Cheaper, Almost as Good: Decrementally Cost-effective medical innovation,” Annals of Internal Medicine 151 (2009): 662–667.

Silveira M. J. Kim S. Y. H. Langa K. M. , “Advance Directives and Outcomes of Surrogate Decision Making before Death,” New England Journal of Medicine 362, no. 13 (2010): 1211–1218.

Emanuel L. , “Advance Care Planning as a Process: Structuring the Discussion in Practice,” Journal of the American Geriatric Society 43, no. 4 (1995): 440–446.

Russ A. J. Kaufman S. R. , “Family Perceptions of Prognosis, Silence, and the ‘Suddenness’ of Death,'” Culture, Medicine and Psychiatry 29, no. 1 (2005): 103–23; Vig E. K. , “Surviving Surrogate Decision-Making: What Helps and Hampers. The Experience of Making Medical Decisions for Others,” Journal of General Internal Medicine 22, no. 9 (2007): 1274–1279.

Danis M. , “Stability of Choices about Life-Sustaining Treatments,” Annals of Internal Medicine 120, no. 7 (1994): 567–573.

See Nicholas , supra note 21.

Pub. L. 111–148, 124 Stat. 119.

See Meropol , supra note 25.

See Singer Lowy , supra note 20; Fries J. F. , “Reducing Health Care Costs by Reducing the Need and Demand for Medical Services,” New England Journal of Medicine 329, no. 5 (1993): 321–325.

See Silveria , supra note 34.

Emanuel E. J. Emanuel L. L. , “The Economics of Dying: The Illusion of Cost Savings at the End of Life,” New England Journal of Medicine 330, no. 8 (1994): 540–544.